Heron Therapeutics | HRTX - Market Capitalization


Heron Therapeutics reported $129.1M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 5.66B 217M May/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amarin USD 290M 51M Dec/2025
ANI Pharmaceuticals USD 1.69B 57M May/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
Eisai JPY 1.25T 171.13B May/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 15.56B 19.73B May/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Pacira USD 915M 149M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Veracyte USD 2.59B 16M May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026